Automated chemistry analyzers are often used to support the drug testing needs of the emergency department. Although this methodology can provide excellent turnaround time, it is limited in its sensitivity and specificity. The purpose of this study was to evaluate the amphetamine immunoassay (VITROS Chemistry AMPH reagents), on the Ortho Vitros Fusion 5,1 FS instrument, to provide support for the University of Utah Hospital emergency department. While evaluating this system, we discovered that patient urine samples that contained high amphetamine and methamphetamine concentrations generated an error code on the instrument and no result (NR) was reported. To mimic the error code, we analyzed urine samples spiked with a range of amphetamine and methamphetamine concentrations in order to characterize this phenomenon.
amphetamine and methamphetamine at concentrations ranging from 800 to 50,000 ng/mL. For all of the 30 specimens that generated a CB error code on the Vitros Fusion instrument, the CB error code was resolved when the samples were diluted prior to repeat analysis. Samples were diluted with blank urine and dilutions ranged from 1:2 to 1:20. As a result, a standard dilution of 1:10 was implemented for samples that generate a CB error code. Qualitative analysis of 71 specimens on the Ortho Vitros 5.1 FS instrument generated 50 positives, 18 negatives, and 3 false negatives. The false negatives occurred in samples that contained only amphetamine, between 1000 and 1200 ng/mL.
To characterize the "CB" error code phenomenon, an in vitro spiking study was performed on 12 blank urine specimens: 10,000 ng/mL of amphetamine stock (Cerilliant) was spiked into each specimen, followed by methamphetamine (Cerilliant) spikes ranging from 250 to 500,000 ng/mL. Spiked samples with a final amphetamine concentration of 5000 ng/mL and methamphetamine concentrations > 12,500 ng/mL generated the CB error code (Table I) . Samples spiked with a final amphetamine concentration of 5000 ng/mL and methamphetamine concentrations < 2500 ng/mL did not generate this error code (Table I) . Surprisingly, samples spiked with methamphetamine alone, up to 500,000 ng/mL, did not generate this error code. It is still unclear why high concentrations of methamphetamine do not cause an error code. The CB error code occurred when samples were spiked with high concentrations of amphetamine alone or in combination with methamphetamine. Moreover, we evaluated the VITROS Chemistry opiate and cocaine reagents and did not observe this same error code phenomenon in urine samples or spikes that had high concentrations of benzoylecgonine (up to 500,000 ng/mL) or morphine (up to 500,000 ng/mL).
High amphetamine and methamphetamine concentrations in urine can cause high absorbance readings beyond the absorbance limits of the instrument and may generate error codes on the Ortho Vitros Fusion 5.1 analyzer. This phenomenon was observed independent of reagent lot and also occurred at another hospital laboratory in Utah. The CB error code was resolved for each of the 30 specimens when the samples were diluted prior to repeat analysis. If sample dilution, prior to repeat analysis, does not resolve the error, the specimen should undergo confirmatory testing by an alternate method. 
